Literature DB >> 27848963

Steatohepatitis: PARP inhibition protective against alcoholic steatohepatitis and NASH.

Katrina Ray.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27848963     DOI： 10.1038/nrgastro.2016.186

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  1 in total

1.  PARP inhibition protects against alcoholic and non-alcoholic steatohepatitis.

Authors:  Partha Mukhopadhyay; Béla Horváth; Mohanraj Rajesh; Zoltán V Varga; Karim Gariani; Dongryeol Ryu; Zongxian Cao; Eileen Holovac; Ogyi Park; Zhou Zhou; Ming-Jiang Xu; Wei Wang; Grzegorz Godlewski; Janos Paloczi; Balazs Tamas Nemeth; Yuri Persidsky; Lucas Liaudet; György Haskó; Peter Bai; A Hamid Boulares; Johan Auwerx; Bin Gao; Pal Pacher
Journal:  J Hepatol       Date:  2016-10-29       Impact factor: 25.083
  1 in total
  4 in total

Review 1.  The role of hyperbaric oxygen therapy in inflammatory bowel disease: a narrative review.

Authors:  Xin Wu; Tian-Yu Liang; Zhong Wang; Gang Chen
Journal:  Med Gas Res       Date:  2021 Apr-Jun

2.  CD169 Expressing Macrophage, a Key Subset in Mesenteric Lymph Nodes Promotes Mucosal Inflammation in Dextran Sulfate Sodium-Induced Colitis.

Authors:  Qiuting Li; Dan Wang; Shengyu Hao; Xiaolei Han; Yuan Xia; Xiangzhi Li; Yaoxing Chen; Masato Tanaka; Chun-Hong Qiu
Journal:  Front Immunol       Date:  2017-06-26       Impact factor: 7.561

3.  NAD+ loss, a new player in AhR biology: prevention of thymus atrophy and hepatosteatosis by NAD+ repletion.

Authors:  Silvia Diani-Moore; Jenny Shoots; Rubi Singh; Joshua B Zuk; Arleen B Rifkind
Journal:  Sci Rep       Date:  2017-05-23       Impact factor: 4.379

4.  Shikonin ameliorated mice colitis by inhibiting dimerization and tetramerization of PKM2 in macrophages.

Authors:  Baoyuan Huang; Qiumei Wang; Lin Jiang; Shuru Lu; Chengcheng Li; Chunqi Xu; Caiyan Wang; Enxin Zhang; Xiaojun Zhang
Journal:  Front Pharmacol       Date:  2022-08-17       Impact factor: 5.988
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.